Unicycive Therapeutics | DEF 14A:股东委托书决议
04/26 17:15 (美东)
Unicycive Therapeutics | ARS:年度报告
04/26 17:15 (美东)
Unicycive Therapeutics | DEFA14A:其他
04/26 17:15 (美东)
Unicycive Therapeutics | 4:持股变动声明-高管 Gupta Shalabh K.
04/17 16:37 (美东)
Unicycive Therapeutics | 4:持股变动声明-高管 Gupta Pramod
04/17 16:36 (美东)
Unicycive Therapeutics | 4:持股变动声明-高管 Jermasek Douglas
04/17 16:35 (美东)
Unicycive Therapeutics | 4:持股变动声明-高管 Townsend John
04/17 16:35 (美东)
Unicycive Therapeutics | PRE 14A:并购重组委托声明
04/16 16:13 (美东)
Unicycive Therapeutics | 8-K:重大事件
03/29 13:28 (美东)
Unicycive Therapeutics | 10-K:年度报表
03/28 16:12 (美东)
Unicycive Therapeutics | D:发行公告
03/20 17:13 (美东)
Unicycive Therapeutics | 8-K:重大事件
03/14 16:31 (美东)
Unicycive Therapeutics | 8-K:重大事件
03/14 16:05 (美东)
Unicycive Therapeutics | 8-K:重大事件
02/21 16:12 (美东)
Unicycive Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
02/14 18:43 (美东)
Unicycive Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%)等
02/14 16:58 (美东)
Unicycive Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(2.73%),Steven Boyd(2.73%)
02/14 15:24 (美东)
Unicycive Therapeutics | SC 13G:超过5%持股股东披露文件-NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP(6.1%)
02/05 12:19 (美东)
Unicycive Therapeutics | SC 13G:超过5%持股股东披露文件-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%)等
01/22 00:00 (美东)
Unicycive Therapeutics | S-8:员工福利计划证券登记
2023/12/08 16:36 (美东)
暂无数据
暂无数据